
News
Erasmus+
Europe drives educational innovation with new Erasmus+ calls
Alliances for Innovation and Centres of Vocational Excellence take centre stage in Key Action 2, with deadlines ranging from February to June 2025
HERA INCUBATOR
According to the new biodefence plan, HERA Incubator, projects with clinical trials will receive funds to fight new COVID-19 variants. Find out about Zabala’s experience in project management related to health.

New Horizon Europe funding to fight variant coronaviruses is now available with a worth of €123 million. As announced a few days ago, the European Commission is mobilising the funding for urgent research on coronavirus variants. The funding is dedicated to fight against COVID-19 and it also contributes to Europe’s overall action to respond to the impact that new variants are having on society, all being in line with the new HERA Incubator scheme. The calls will open on the 13th of April and the deadline for submission will be on the 6th of May 2021.
Following the Commission’s announcement, the EU Commissioner for Innovation, Research, Culture, Education and Youth stressed: “We continue to mobilise all the means at our disposal to fight this pandemic and the challenges posed by new variants.”
Funded projects should meet some of the following objectives:
Health is one of the areas of knowledge in which Zabala has the greatest expertise, something that is particularly valuable in this period of the global pandemic we are facing. We have experience in the management of different projects involving clinical trials. Among others, Zabala is involved in the management of the HIVACAR project, which aims to change the current paradigm of HIV treatment by obtaining a functional cure. It has a budget of almost 7 million euros, has 14 partners and is part of the Horizon 2020 programme.
We also collaborate in the DOCTIS project, which aims to improve the efficacy of the treatment of six immune-mediated inflammatory diseases: Crohn’s disease, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, psoriasis and psoriatic arthritis. The project involves 10 partners and has a funding of €6 million.

News
Erasmus+
Alliances for Innovation and Centres of Vocational Excellence take centre stage in Key Action 2, with deadlines ranging from February to June 2025

Opinion
COMMUNICATION

Arantxa Iborra
Consultant in Dissemination of European Projects

Publication
Innovation Fund Programme
Uncover the key insights of the Innovation Fund programme, to boost the chances of securing funding for your projects
Europe offers many opportunities to support and foster Research, Development and Innovation actions. Competition is high and being well positioned among stakeholders active in each sector requires a well thought-out plan of action and an active way of promoting visibility in Brussels.
We are experts in European funding programmes, which provide the opportunity to finance the development and market access of your company's innovative projects.
We provide advice to activities that encourage innovation, aimed at promoting the development of new innovative markets from the demand side, through public procurement.